FDA
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
-
-
-
-
-
-
-
Phio Pharmaceuticals Corp. (PHIO) Prices 833.3K Share Offering at $3/sh
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
-
325,025 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

